摘要 |
This invention provides a method of treating a subject afflicted with multiple syndrome (CIS) sclerosis (MS), comprising a method of treating a subject afflicted with MS by a) administering to the subject an amount of an anti-CD52 antibody, followed by b) periodically administering to the subject an amount of laquinimod. This invention also provides packages comprising pharmaceutical compositions of laquinimod or an anti-CD52 antibody for treating a subject afflicted with MS wherein, laquinimod is a maintenance therapy in treating MS and wherein the subject has received an anti-CD52 antibody induction therapy. |